Cheng, Gang
Hardy, Micael
You, Ming
Kalyanaraman, Balaraman
Funding for this research was provided by:
Harry R. and Angeline E. Quadracci Professor in Parkinson’s Research Endowment
Article History
Received: 22 December 2021
Accepted: 14 March 2022
First Online: 24 March 2022
Competing interests
: Gang Cheng, Micael Hardy, and Balaraman Kalyanaraman are inventors of WO2021081500A1, “Mitochondria-targeted atovaquone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug,” which is under consideration by the US Patent and Trademark Office. Ming You does not have any competing interests to declare.